{"name":"Curacell Holding AB","slug":"curacell-holding-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Uromitexan","genericName":"Uromitexan","slug":"uromitexan","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Uromitexan","genericName":"Uromitexan","slug":"uromitexan","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1oTXNjX1dLeXBCak1kangxcV9CWXFITlpKTnBUN2FzQ05za3NsVzJmczNyZVF4blBmT1M4cVdmQmo5OEdHN3V0Nk50QldzdUYyNUxDLXp6ZENvZzJibF92X28zSzdVZnFnT0dObDVySQ?oc=5","date":"2025-08-14","type":"regulatory","source":"Clinical Trials Arena","summary":"CuraCell gains German approval for trial application of CC-38 - Clinical Trials Arena","headline":"CuraCell gains German approval for trial application of CC-38","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}